Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Braz. dent. j ; 31(5): 458-465, Sept.-Oct. 2020. tab, graf
Article in English | LILACS, BBO | ID: biblio-1132332

ABSTRACT

Abstract This study aims to evaluate the post-extraction alveolar bone reconstruction amongst 12 patients exhibiting loss of buccal bone plate in a tooth of the anterior region of the maxilla using the prosthetically-driven alveolar reconstruction technique (PDAR). In PDAR, a partial fixed provisional prosthesis (PFPP [conventional or adhesive]) with a specially designed pontic maintains the clot in a mechanically stable position during alveolar regeneration. Moreover, the pontic design, in hourglass shape and located in the subgingival area, also prevents gingival margins from collapsing. Gingival recession was evaluated through the 6-month healing period. Cone beam computed tomography (CBCT) was performed 1 month before and 8 months after PDAR treatment. For the primary outcome, in the panoramic imaging, the central area of bone defect in each tooth was selected for linear measurements. Measurements of the vertical buccal bone gain and the gain in thickness in the alveolar bone crest were obtained 8 months after PDAR. Descriptive statistics and intraclass correlation coefficient analysis were conducted. After treatment, all patients showed bone formation (a mean vertical gain of 7.1±3.7 mm, associated with a horizontal mean gain of 4.5±1.4 mm in the alveolar bone crest). The intraclass correlation coefficient for the measurements performed using CBCT was 0.999. No gingival recession, greater than 1 mm, was observed. Lower-morbidity procedures without the use of biomaterials may be a useful in post-extraction alveolar ridge regeneration and/or preservation. PDAR promoted alveolar bone formation without flaps, grafts and membranes.


Resumo Este estudo teve como objetivo avaliar a reconstrução do osso alveolar após extração em 12 pacientes com perda da tábua óssea vestibular em dentes na região anterior da maxila usando a técnica da reconstrução alveolar proteticamente guiada (RAPG). Na RAPG, uma prótese parcial fixa provisória (PPFP [convencional ou adesiva]) com um pôntico com design específico mantém o coágulo numa posição mecanicamente estável. Além disso, o design do pôntico, com formato de ampulheta e localizado na área subgengival, também previne o colapso das margens gengivais. A recessão gengival foi avaliada durante o período de cicatrização de 6 meses. Tomografias computadorizadas cone beam (TCCB) foram feitas 1 mês antes e 8 meses após o tratamento com a RAPG. Para o desfecho primário, nas imagens panorâmicas, a área central do defeito ósseo em cada dente foi selecionada para as medições lineares. As medições do ganho vertical ósseo vestibular e do ganho em espessura na crista óssea alveolar foram realizadas. A análise estística descritiva e a análise do coeficiente de correlação intraclasse forma realizados. Após o tratamento, todos os pacientes apresentaram formação óssea (ganho vertical médio de 7,1±3,7 mm, associado a ganho horizontal médio de 4,5±1,4 mm na crista óssea alveolar). O coeficiente de correlação intraclasse foi de 0,999. Nenhuma retração gengival acima de 1 mm foi observada. Procedimentos com baixa morbidade sem o uso de biomateriais podem ser úteis na regeneração/preservação do rebordo após as extrações. A RAPG promove a formação do osso alveolar sem o uso de retalhos, enxertos e membranas.


Subject(s)
Humans , Alveolar Bone Loss/diagnostic imaging , Tooth Socket , Tooth Extraction , Retrospective Studies , Cone-Beam Computed Tomography , Alveolar Process/surgery , Alveolar Process/diagnostic imaging , Maxilla
2.
J. venom. anim. toxins incl. trop. dis ; 25: e20190038, 2019. tab, ilus
Article in English | LILACS, VETINDEX | ID: biblio-1040381

ABSTRACT

Fibrin biopolymers, previously referred as "fibrin glue" or "fibrin sealants", are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was "heterologous fibrin sealant". The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.(AU)


Subject(s)
Biopolymers , Fibrin , Hemostatics , Thrombin
3.
J. venom. anim. toxins incl. trop. dis ; 23: 21, 2017. tab, graf, ilus
Article in English | LILACS, VETINDEX | ID: biblio-954833

ABSTRACT

Hemostatic and adhesive agents date back to World War II, when homologous fibrin sealant came onto scene. Considering that infectious diseases can be transmitted via human blood, a new heterologous fibrin sealant was standardized in the 1990s. Its components were a serine protease (a thrombin-like enzyme) extracted from the venom of Crotalus durissus terrificus snakes and a fibrinogen-rich cryoprecipitate extracted from the blood of Bubalus bubalis buffaloes. This new bioproduct has been used as a coagulant, sealant, adhesive and recently as a candidate scaffold for mesenchymal stem cells and bone and cartilage repair. This review discusses the composition of a new heterologous fibrin sealant, and cites published articles related to its preclinical applications aiming at repairing nervous system traumas and regenerating bone marrow. Finally, we present an innovative safety trial I/II that found the product to be a safe and clinically promising candidate for treating chronic venous ulcers. A multicenter clinical trial, phase II/III, with a larger number of participants will be performed to prove the efficacy of an innovative biopharmaceutical product derived from animal venom.(AU)


Subject(s)
Animals , Snake Venoms , Fibrinogen , Fibrin Tissue Adhesive , Serine Proteases , Crotalid Venoms
4.
Article in English | LILACS-Express | LILACS, VETINDEX | ID: biblio-1484695

ABSTRACT

Abstract Hemostatic and adhesive agents date back to World War II, when homologous fibrin sealant came onto scene. Considering that infectious diseases can be transmitted via human blood, a new heterologous fibrin sealant was standardized in the 1990s. Its components were a serine protease (a thrombin-like enzyme) extracted from the venom of Crotalus durissus terrificus snakes and a fibrinogen-rich cryoprecipitate extracted from the blood of Bubalus bubalis buffaloes. This new bioproduct has been used as a coagulant, sealant, adhesive and recently as a candidate scaffold for mesenchymal stem cells and bone and cartilage repair. This review discusses the composition of a new heterologous fibrin sealant, and cites published articles related to its preclinical applications aiming at repairing nervous system traumas and regenerating bone marrow. Finally, we present an innovative safety trial I/II that found the product to be a safe and clinically promising candidate for treating chronic venous ulcers. A multicenter clinical trial, phase II/III, with a larger number of participants will be performed to prove the efficacy of an innovative biopharmaceutical product derived from animal venom.

5.
Araçatuba; s.n; 2008. 66 p. ilus, tab, graf.
Thesis in Portuguese | LILACS, BBO | ID: lil-671252

ABSTRACT

O objetivo deste estudo experimental foi comparar histologicamente o reparo ósseo ao redor de implantes preenchidos por coágulo local com ou sem a associação de centrifugado de medula óssea, por meio de análises histológica e histométrica. Doze coelhos receberam dois implantes osseointegráveis em cada tíbia direita, onde a primeira cortical foi preparada com 5 mm e a segunda, ou cortical inferior, com 3 mm. Os implantes foram estabilizados na cortical inferior com 40 N, sendo um defeito preenchido por coagulo sanguíneo e o outro com coágulo e centrifugado de medula óssea. O sacrifício dos animais foi realizado nos períodos de 7, 21 e 60 dias. As peças foram submetidas a processamento laboratorial de rotina e coradas com vermelho de alizarina e azul de Stevenel. Tanto o grupo coágulo quanto o grupo coágulo e centrifugado de medula, após 60 dias, tiveram seus defeitos preenchidos por tecido ósseo, não apresentando diferença estatística entre os grupos quanto à extensão linear de contato entre tecido ósseo e implante


The objective of this experimental study was to compare histologically the bone repair around implant filled out by local coagulum with or without association of bone marrow centrifuged through histological and histometric analysis. Twelve rabbits received two implants in the right tibia, where the first cortical it was prepared with 5 mm and the second or lower cortical, with 3 mm. The implants were stabilized in lower cortical with 40 N, being one defect filled out by blood coagulum and the other filled out by blood coagulum and bone marrow centrifuged. The sacrifice of the animals was accomplished in the periods of 7, 21 and 60 days. The pieces were submitted to routine laboratorial process and stained with alizarin red and Stevenel’s blue. Both groups had their defects filled by bone after 60 days, not presenting statistical difference between the groups about the linear extension of contact between bone tissue and implant


Subject(s)
Animals , Rabbits , Bone Marrow , Dental Implantation , Dental Implantation, Endosseous , Rabbits
6.
Araçatuba; s.n; 2008. 66 p. ilus, tab, graf.
Thesis in Portuguese | LILACS, BBO | ID: biblio-866154

ABSTRACT

O objetivo deste estudo experimental foi comparar histologicamente o reparo ósseo ao redor de implantes preenchidos por coágulo local com ou sem a associação de centrifugado de medula óssea, por meio de análises histológica e histométrica. Doze coelhos receberam dois implantes osseointegráveis em cada tíbia direita, onde a primeira cortical foi preparada com 5 mm e a segunda, ou cortical inferior, com 3 mm. Os implantes foram estabilizados na cortical inferior com 40 N, sendo um defeito preenchido por coagulo sanguíneo e o outro com coágulo e centrifugado de medula óssea. O sacrifício dos animais foi realizado nos períodos de 7, 21 e 60 dias. As peças foram submetidas a processamento laboratorial de rotina e coradas com vermelho de alizarina e azul de Stevenel. Tanto o grupo coágulo quanto o grupo coágulo e centrifugado de medula, após 60 dias, tiveram seus defeitos preenchidos por tecido ósseo, não apresentando diferença estatística entre os grupos quanto à extensão linear de contato entre tecido ósseo e implante


The objective of this experimental study was to compare histologically the bone repair around implant filled out by local coagulum with or without association of bone marrow centrifuged through histological and histometric analysis. Twelve rabbits received two implants in the right tibia, where the first cortical it was prepared with 5 mm and the second or lower cortical, with 3 mm. The implants were stabilized in lower cortical with 40 N, being one defect filled out by blood coagulum and the other filled out by blood coagulum and bone marrow centrifuged. The sacrifice of the animals was accomplished in the periods of 7, 21 and 60 days. The pieces were submitted to routine laboratorial process and stained with alizarin red and Stevenel’s blue. Both groups had their defects filled by bone after 60 days, not presenting statistical difference between the groups about the linear extension of contact between bone tissue and implant


Subject(s)
Animals , Rabbits , Bone Marrow , Dental Implants , Rabbits
7.
Korean Journal of Urology ; : 39-44, 1984.
Article in Korean | WPRIM | ID: wpr-165687

ABSTRACT

Successful removal of staghorn and multiple renal calculi has been one of the mist difficult tasks that confront the urologists. The operative method for removal of the renal calculi was selected according to the size, number, location and anatomic features of the renal collecting system. We utilized the coagulum to improve the success of the stone removal for last five months. The coagulum material were mixed in a ratio of 5ml cryoprecipitate or 4% fibrinogen: 1ml 20 unit /ml human thrombin:0.2ml 10% calcium chloride. The results were as follows. 1. The patients were provided by 3 coagulum pyelolithotomy and 6 coagulum nephrolithotomy, of which utilized cryoprecipitate in 7 cases and 4% fibrinogen in 2 for the fibrinogen source. 2. The seven of nine cases(78.2%) were successfully removed without residual stone, but incompletely in two cases(22.2%). 3. Nondemonstrable stone of the preliminary film were removed additionally in one cases(11.1%). 4. As to the complication, meaningless wound infection and dehiscence was observed in only one case. On basis of our experiences, present here a histologic perspectives, methods, cases and its results, in dication and contraindication for coagulum pyelolithotomy and nephrolithotomy.


Subject(s)
Humans , Calcium Chloride , Fibrinogen , Kidney Calculi , Wound Infection
SELECTION OF CITATIONS
SEARCH DETAIL